NCT00139061 - Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate | Biotech Hunter

Enrollment

128

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

May 31, 2006

Conditions

Hyperlipidemia

Interventions

DRUG

Torcetrapib/Atorvastatin

DRUG

Fenofibrate

Trial Locations (26)

21000

Pfizer Investigational Site, Dijon

31600

Pfizer Investigational Site, Seysses

40000

Pfizer Investigational Site, Mont-de-Marsan

40010

Pfizer Investigational Site, Mont-de-Marsan

40090

Pfizer Investigational Site, Saint-Martin-d'Oney

49125

Pfizer Investigational Site, Briollay

49610

Pfizer Investigational Site, Mûrs-Erigné

54660

Pfizer Investigational Site, Moûtiers

54800

Pfizer Investigational Site, Jarny

Pfizer Investigational Site, Mars-la-Tour

57070

Pfizer Investigational Site, Metz

67000

Pfizer Investigational Site, Strasbourg

79100

Pfizer Investigational Site, Thouars

49 000

Pfizer Investigational Site, Angers

49 100

Pfizer Investigational Site, Angers

33 200

Pfizer Investigational Site, Bordeaux Cauderan

57 300

Pfizer Investigational Site, Hagondange

40 280

Pfizer Investigational Site, Haut-Mauco

59 037 Cedex

Pfizer Investigational Site, Lille

32 240

Pfizer Investigational Site, Monguilhem

40 010 cedex

Pfizer Investigational Site, Mont-de-Marsan

40 010

Pfizer Investigational Site, Mont-de-Marsan

44 093 Cedex 01

Pfizer Investigational Site, Nantes

21 850

Pfizer Investigational Site, Pouilly-en-Auxois

40 240

Pfizer Investigational Site, Saint-Justin

49 125

Pfizer Investigational Site, Tiercé